Scienture Holdings SCNX
NASDAQ SCNX
$0.37 +0.01 (+1.66%)
At close: Sep 9, 2026 · 4:00 PM EDT

Scienture Holdings (SCNX) Common Equity (2013 - 2026)

Scienture Holdings' (SCNX) quarterly Common Equity came in at $64.1 million in Q2 2026, down 17.67% year-over-year from $77.9 million in Q2 2025, and down 4.07% quarter-over-quarter from $66.8 million in Q1 2026.

Analysis

Scienture Holdings (SCNX) Common Equity (2013 - 2026) Analysis & Trends

Scienture Holdings has disclosed Common Equity across 14 years of filings, most recently posting $64.1 million for Q2 2026.

  • In Q2 2026, Common Equity fell 17.67% year-over-year to $64.1 million; the TTM figure through Jun 2026 stood at $64.1 million (down 17.67% YoY), while the FY2025 annual figure was $70.1 million, down 29.88% from the prior year.
  • Common Equity came in at $64.1 million for Q2 2026 at Scienture Holdings, down from $66.8 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $100.0 million in Q1 2023 to a low of -$1.3 million in Q2 2023.
  • Average Common Equity over 5 years is $43.4 million, with a median of $38.9 million recorded in 2024.
  • Year-over-year, Common Equity sank 171.74% in 2023 and jumped 14479.46% in 2024.
  • Over 5 years, Common Equity stood at $342867.0 in 2022, then jumped by 58.18% to $542353.0 in 2023, then jumped by 14479.46% to $79.1 million in 2024, then declined by 11.32% to $70.1 million in 2025, then slipped by 8.58% to $64.1 million in 2026.
  • Per Business Quant data, the three most recent Common Equity figures were $64.1 million in Q2 2026, $66.8 million in Q1 2026, and $70.1 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Teva Pharmaceutical Industries 42.34 Bn 38.68 Bn 2.15 Bn 7.76 Bn
2 Viatris 19.39 Bn 18.50 Bn 1.46 Bn 14.26 Bn
3 Dr Reddys Laboratories 9.99 Bn 9.85 Bn 396.53 Mn 4.08 Bn
4 Amneal Pharmaceuticals 5.57 Bn 5.53 Bn 334.51 Mn 33.02 Mn
5 Bausch Health Companies 2.45 Bn 1.58 Bn 2.10 Bn -1.77 Bn
6 Ani Pharmaceuticals 1.70 Bn 1.34 Bn 165.89 Mn 597.21 Mn
7 Alvotech 1.66 Bn 1.52 Bn 2.56 Mn -191.48 Mn
8 Amphastar Pharmaceuticals 985.90 Mn 695.77 Mn 93.47 Mn 768.16 Mn
9 Fennec Pharmaceuticals 434.07 Mn 392.82 Mn 17.15 Mn 42.44 Mn
10 Scienture Holdings 15.19 Mn 15.19 Mn 335,779.00 64.10 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 64.10 Mn
Mar 31, 2026 66.82 Mn
Dec 31, 2025 70.12 Mn
Sep 30, 2025 100.00 Mn
Jun 30, 2025 77.86 Mn
Mar 31, 2025 81.16 Mn
Dec 31, 2024 79.07 Mn
Sep 30, 2024 100.00 Mn
Jun 30, 2024 11.79 Mn
Mar 31, 2024 13.62 Mn
Dec 31, 2023 542,353.00
Sep 30, 2023 11.56 Mn
Jun 30, 2023 -1.29 Mn
Mar 31, 2023 100.00 Mn
Dec 31, 2022 342,867.00
Sep 30, 2022 1.36 Mn
Jun 30, 2022 1.80 Mn
Mar 31, 2022 2.89 Mn
Dec 31, 2021 3.77 Mn
Sep 30, 2021 4.62 Mn